Evidence map›Paper›PMID 30734983›Full record

ArticleHIV medicine2019

Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.

D De Francesco, J Underwood, E Bagkeris, M Boffito, F A Post, Pwg Mallon, J H Vera, I Williams, J Anderson, M Johnson and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in HIV medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01737047 (A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in England and Ireland), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01737047 completednot on this map

A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in England and Ireland

TypeobservationalSponsorImperial College LondonRan2013 to 2023Enrolled1,377ConditionsHIV Positive, Ageing
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

D De FrancescoInstitute for Global Health, University College London, London, UK.ORCID 0000-0002-6185-0514
J UnderwoodDivision of Infectious Diseases, Imperial College London, London, UK.ORCID 0000-0001-6963-2821
E BagkerisInstitute for Global Health, University College London, London, UK.
M BoffitoChelsea and Westminster Healthcare NHS Foundation Trust, London, UK.
F A PostKing's College Hospital NHS Foundation Trust, London, UK.
Pwg MallonUniversity College Dublin School of Medicine, Dublin, Ireland.
J H VeraBrighton and Sussex Medical School, Brighton, UK.
I WilliamsMortimer Market Centre, University College London, London, UK.
J AndersonHomerton University Hospital, London, UK.
M JohnsonRoyal Free Hospital NHS Trust, London, UK.
C A SabinInstitute for Global Health, University College London, London, UK.ORCID 0000-0001-5173-2760
A WinstonDivision of Infectious Diseases, Imperial College London, London, UK.
Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study

Funding

Medical Research Council MR/M004236/1
6 · The paper itself

Abstract

objectivesWe investigated whether differences in cognitive performance between people living with HIV (PLWH) and comparable HIV-negative people were mediated or moderated by depressive symptoms and lifestyle factors.

methodsA cross-sectional study of 637 'older' PLWH aged ≥ 50 years, 340 'younger' PLWH aged < 50 years and 276 demographically matched HIV-negative controls aged ≥ 50 years enrolled in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) study was performed. Cognitive function was assessed using a computerized battery (CogState). Scores were standardized into Z-scores [mean = 0; standard deviation (SD) = 1] and averaged to obtain a global Z-score. Depressive symptoms were evaluated via the Patient Health Questionnaire (PHQ-9). Differences between the three groups and the effects of depression, sociodemographic factors and lifestyle factors on cognitive performance were evaluated using median regression. All analyses accounted for age, gender, ethnicity and level of education.

resultsAfter adjustment for sociodemographic factors, older and younger PLWH had poorer overall cognitive scores than older HIV-negative controls (P < 0.001 and P = 0.006, respectively). Moderate or severe depressive symptoms were more prevalent in both older (27%; P < 0.001) and younger (21%; P < 0.001) PLWH compared with controls (8%). Depressive symptoms (P < 0.001) and use of hashish (P = 0.01) were associated with lower cognitive function; alcohol consumption (P = 0.02) was associated with better cognitive scores. After further adjustment for these factors, the difference between older PLWH and HIV-negative controls was no longer significant (P = 0.08), while that between younger PLWH and older HIV-negative controls remained significant (P = 0.01).

conclusionsPoorer cognitive performances in PLWH compared with HIV-negative individuals were, in part, mediated by the greater prevalence of depressive symptoms and recreational drug use reported by PLWH.

Indexed as

CognitionLife StyleAdultAgedCross-Sectional StudiesDepressive DisorderFemaleHIV InfectionsHumansMaleMiddle AgedSubstance-Related DisordersYoung Adultcognitive disordercognitive functiondepressionHIVHIV-associated neurocognitive disorderspeople living with HIV

Identifiers

PMID30734983
PMCPMC6593457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.